• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于钆贝葡胺增强 MRI 的深度学习与影像组学特征融合的预测模型用于肝细胞癌术后早期复发

A predictive model integrating deep and radiomics features based on gadobenate dimeglumine-enhanced MRI for postoperative early recurrence of hepatocellular carcinoma.

机构信息

Digital Medical Research Center, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.

Shanghai Key Laboratory of Medical Imaging Computing and Computer Assisted Intervention, Shanghai, 200032, China.

出版信息

Radiol Med. 2022 Mar;127(3):259-271. doi: 10.1007/s11547-021-01445-6. Epub 2022 Feb 7.

DOI:10.1007/s11547-021-01445-6
PMID:35129757
Abstract

PURPOSE

Hepatocellular carcinoma (HCC) is the most common liver cancer worldwide, and early recurrence of HCC after curative hepatic resection is indicative of poor prognoses. We aim to develop a predictive model for postoperative early recurrence of HCC based on deep and radiomics features from multi-phasic magnetic resonance imaging (MRI).

MATERIALS AND METHODS

A total of 472 HCC patients were included and divided into the training (n = 378) and validation (n = 94) cohorts in the retrospective study. We separately extracted radiomics features and deep features from eight phases of gadoxetic acid-enhanced MRI and utilized the least absolute shrinkage and selection operator logistic regression algorithm for feature selection and model construction. We integrated the selected two types of features into a combined model and established a radiomics model as well as a deep learning (DL) model for comparison.

RESULTS

In the training and validation cohorts, the combined model demonstrated better performance for stratifying patients at high risk of early recurrence (AUC of 0.911 and 0.840, accuracy of 0.779 and 0.777, sensitivity of 0.927 and 0.769, specificity 0.720 and 0.779) than the radiomics model (AUC of 0.740 and 0.780) and the DL model (AUC of 0.887 and 0.813).

CONCLUSION

The combined model integrating deep and radiomics features from multi-phasic MRI is efficient for noninvasively stratifying patients at high risk of early HCC recurrence after resection.

摘要

目的

肝细胞癌(HCC)是全球最常见的肝癌,HCC 根治性肝切除术后的早期复发提示预后不良。我们旨在开发一种基于多期磁共振成像(MRI)的深度学习和放射组学特征预测 HCC 术后早期复发的模型。

材料和方法

回顾性研究共纳入 472 例 HCC 患者,分为训练队列(n=378)和验证队列(n=94)。我们分别从钆塞酸增强 MRI 的 8 个时相提取放射组学特征和深度学习特征,并利用最小绝对收缩和选择算子逻辑回归算法进行特征选择和模型构建。我们将选择的两种类型的特征整合到一个联合模型中,并建立了放射组学模型和深度学习模型进行比较。

结果

在训练队列和验证队列中,联合模型在分层高复发风险的患者方面表现出更好的性能(AUC 为 0.911 和 0.840,准确性为 0.779 和 0.777,敏感性为 0.927 和 0.769,特异性为 0.720 和 0.779),优于放射组学模型(AUC 为 0.740 和 0.780)和深度学习模型(AUC 为 0.887 和 0.813)。

结论

该联合模型整合了多期 MRI 的深度学习和放射组学特征,可有效对术后早期 HCC 复发高风险患者进行分层。

相似文献

1
A predictive model integrating deep and radiomics features based on gadobenate dimeglumine-enhanced MRI for postoperative early recurrence of hepatocellular carcinoma.基于钆贝葡胺增强 MRI 的深度学习与影像组学特征融合的预测模型用于肝细胞癌术后早期复发
Radiol Med. 2022 Mar;127(3):259-271. doi: 10.1007/s11547-021-01445-6. Epub 2022 Feb 7.
2
A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.基于影像组学的钆塞酸增强 MRI 肝细胞癌细胞角蛋白 19 状态的生物标志物
Eur Radiol. 2020 May;30(5):3004-3014. doi: 10.1007/s00330-019-06585-y. Epub 2020 Jan 30.
3
Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction.肝细胞癌:钆塞酸增强 MRI 的影像组学列线图预测早期术后复发。
Cancer Imaging. 2019 May 14;19(1):22. doi: 10.1186/s40644-019-0209-5.
4
Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.基于术前钆塞酸增强 MRI 的放射组学模型预测肝衰竭。
World J Gastroenterol. 2020 Mar 21;26(11):1208-1220. doi: 10.3748/wjg.v26.i11.1208.
5
Computed tomography-based radiomics to predict early recurrence of hepatocellular carcinoma post-hepatectomy in patients background on cirrhosis.基于计算机断层扫描的放射组学预测肝硬化背景下肝癌患者肝切除术后早期复发。
World J Gastroenterol. 2024 Apr 21;30(15):2128-2142. doi: 10.3748/wjg.v30.i15.2128.
6
Machine learning based on gadoxetic acid-enhanced MRI for differentiating atypical intrahepatic mass-forming cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.基于钆塞酸二钠增强磁共振成像的机器学习用于鉴别非典型肝内肿块型胆管癌与低分化肝细胞癌
Abdom Radiol (NY). 2023 Aug;48(8):2525-2536. doi: 10.1007/s00261-023-03870-9. Epub 2023 May 11.
7
Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: a two-center study.使用钆塞酸二钠增强MRI的影像组学和机器学习模型预测肝细胞癌病理分级:一项双中心研究
Abdom Radiol (NY). 2023 Jan;48(1):244-256. doi: 10.1007/s00261-022-03679-y. Epub 2022 Sep 21.
8
Radiomics model based on contrast-enhanced computed tomography to predict early recurrence in patients with hepatocellular carcinoma after radical resection.基于增强 CT 的影像组学模型预测肝癌根治性切除术后早期复发。
World J Gastroenterol. 2023 Jul 14;29(26):4186-4199. doi: 10.3748/wjg.v29.i26.4186.
9
Radiomics-based model using gadoxetic acid disodium-enhanced MR images: associations with recurrence-free survival of patients with hepatocellular carcinoma treated by surgical resection.基于钆塞酸二钠增强磁共振图像的放射组学模型:与手术切除治疗的肝细胞癌患者无复发生存率的相关性。
Abdom Radiol (NY). 2021 Aug;46(8):3845-3854. doi: 10.1007/s00261-021-03034-7. Epub 2021 Mar 18.
10
Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.基于动态对比增强磁共振成像的放射组学术前预测巨梁型/块状型肝细胞癌。
World J Gastroenterol. 2023 Apr 7;29(13):2001-2014. doi: 10.3748/wjg.v29.i13.2001.

引用本文的文献

1
Multi-parameter MRI-based model for the prediction of early recurrence of hepatitis B-associated hepatocellular carcinoma after microwave ablation.基于多参数磁共振成像的模型用于预测微波消融术后乙型肝炎相关肝细胞癌的早期复发
Front Cell Infect Microbiol. 2025 Aug 27;15:1638779. doi: 10.3389/fcimb.2025.1638779. eCollection 2025.
2
Predictive Radiomics-Based Model for Recurrence-Free Survival After Curative Resection in Patients with Hepatocellular Carcinoma.基于预测性放射组学的肝细胞癌患者根治性切除术后无复发生存模型
J Hepatocell Carcinoma. 2025 Aug 7;12:1755-1766. doi: 10.2147/JHC.S535492. eCollection 2025.
3

本文引用的文献

1
Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns.晚期非小细胞肺癌中不常见的 EGFR 外显子 20 插入突变的治疗探索:披荆斩棘。
J Cancer Res Clin Oncol. 2022 Jan;148(1):163-176. doi: 10.1007/s00432-021-03840-y. Epub 2021 Oct 26.
2
A Radiomics Nomogram for Preoperative Prediction of Early Recurrence of Small Hepatocellular Carcinoma After Surgical Resection or Radiofrequency Ablation.一种用于术前预测小肝细胞癌手术切除或射频消融后早期复发的影像组学列线图。
Front Oncol. 2021 Apr 29;11:657039. doi: 10.3389/fonc.2021.657039. eCollection 2021.
3
Radiomics analysis based on dynamic contrast-enhanced MRI for predicting early recurrence after hepatectomy in hepatocellular carcinoma patients.
基于动态对比增强磁共振成像的影像组学分析预测肝细胞癌患者肝切除术后早期复发
Sci Rep. 2025 Jul 1;15(1):22240. doi: 10.1038/s41598-025-02291-6.
4
MRI Imaging Biomarkers for Prognostication of Hepatocellular Carcinoma.用于肝细胞癌预后评估的MRI成像生物标志物
J Korean Soc Radiol. 2025 May;86(3):364-380. doi: 10.3348/jksr.2025.0029. Epub 2025 May 28.
5
Insights into radiomics: a comprehensive review for beginners.放射组学洞察:面向初学者的全面综述
Clin Transl Oncol. 2025 May 12. doi: 10.1007/s12094-025-03939-5.
6
Research progress of MRI-based radiomics in hepatocellular carcinoma.基于MRI的放射组学在肝细胞癌中的研究进展
Front Oncol. 2025 Feb 6;15:1420599. doi: 10.3389/fonc.2025.1420599. eCollection 2025.
7
Artificial intelligence in fracture detection on radiographs: a literature review.人工智能在X线片骨折检测中的应用:文献综述
Jpn J Radiol. 2025 Apr;43(4):551-585. doi: 10.1007/s11604-024-01702-4. Epub 2024 Nov 14.
8
Percutaneous microwave ablation of HCC: comparison between 100 and 150 W technology systems.经皮微波消融治疗肝癌:100W与150W技术系统的比较
Radiol Med. 2024 Dec;129(12):1916-1925. doi: 10.1007/s11547-024-01927-3. Epub 2024 Nov 8.
9
Artificial intelligence in predicting recurrence after first-line treatment of liver cancer: a systematic review and meta-analysis.人工智能在预测肝癌一线治疗后复发中的应用:系统评价和荟萃分析。
BMC Med Imaging. 2024 Oct 7;24(1):263. doi: 10.1186/s12880-024-01440-z.
10
Multicenter Integration of MR Radiomics, Deep Learning, and Clinical Indicators for Predicting Hepatocellular Carcinoma Recurrence After Thermal Ablation.用于预测热消融术后肝细胞癌复发的磁共振成像放射组学、深度学习和临床指标的多中心整合
J Hepatocell Carcinoma. 2024 Oct 2;11:1861-1874. doi: 10.2147/JHC.S482760. eCollection 2024.
Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy.
基于多参数磁共振成像的放射组学分析预测肝细胞癌肝部分切除术后早期复发
J Magn Reson Imaging. 2021 Apr;53(4):1066-1079. doi: 10.1002/jmri.27424. Epub 2020 Nov 20.
4
Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction.肝细胞癌:钆塞酸增强 MRI 的影像组学列线图预测早期术后复发。
Cancer Imaging. 2019 May 14;19(1):22. doi: 10.1186/s40644-019-0209-5.
5
CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation.基于 CT 的肿瘤周围放射组学特征预测肝癌根治性切除或消融术后早期复发。
Cancer Imaging. 2019 Feb 27;19(1):11. doi: 10.1186/s40644-019-0197-5.
6
Radiomics on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma.钆塞酸二钠增强磁共振成像的影像组学用于预测单发性肝细胞癌术后早期和晚期复发
Clin Cancer Res. 2019 Jul 1;25(13):3847-3855. doi: 10.1158/1078-0432.CCR-18-2861. Epub 2019 Feb 26.
7
Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.肝脏影像报告和数据系统(LI-RADS)2018 版:高危患者肝细胞癌的影像学表现。
Radiology. 2018 Dec;289(3):816-830. doi: 10.1148/radiol.2018181494. Epub 2018 Sep 25.
8
Pattern Classification for Gastrointestinal Stromal Tumors by Integration of Radiomics and Deep Convolutional Features.基于放射组学和深度卷积特征融合的胃肠道间质瘤分类。
IEEE J Biomed Health Inform. 2019 May;23(3):1181-1191. doi: 10.1109/JBHI.2018.2841992. Epub 2018 May 29.
9
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.肝细胞癌的诊断、分期及管理:美国肝病研究协会2018年实践指南
Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.
10
Hepatocellular carcinoma.肝细胞癌。
Lancet. 2018 Mar 31;391(10127):1301-1314. doi: 10.1016/S0140-6736(18)30010-2. Epub 2018 Jan 5.